This study has proposed four types of therapeutics including chimeric vaccine, potent drugs, siRNAs and ISG targets against COVID–19. We have analyzed all the genomic, host transcriptomic and proteomic data to anticipate the possible therapeutics against the recent pandemic COVID–19. Therefore, these findings might be of interest to the researchers and pharmaceuticals company to discover the novel therapeutics against the SARS-CoV–2. Full work published in
Gene.